Michael J. Higgins, Director at Voyager Therapeutics, Inc. (VYGR), sold 27,782 shares at $6.70 ($186K) on 2022-07-14, disclosed to the SEC on 2022-07-18.
Open-market sale of $186k VYGR by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $6.70 | 13,891 | $93K | 50.0% |
| 2 | $6.70 | 13,891 | $93K | 50.0% |
| Total | $6.70 avg | 27,782 | $186K | 100% |
| Filing → |
| IRWD | SELL | 2014-05-30 | $728K | — | Filing → |
| IRWD | SELL | 2013-06-18 | $1.8M | — | Filing → |
| IRWD | SELL | 2013-03-07 | $779K | — | Filing → |